Skip to main content
Clinical Trials/NCT06513442
NCT06513442
Not yet recruiting
Not Applicable

The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust0 sites1,500 target enrollmentAugust 1, 2024
ConditionsOsteoporosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Enrollment
1500
Primary Endpoint
To assess the newest version of TBS software on fracture prediction
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

  1. To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip.
  2. To assess the clinical utility of TBS software as a potential treatment outcome: sensitivity to change over time and following osteoporosis therapy.
  3. To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography (QCT) in fracture risk prediction and response to osteoporosis therapy.
Registry
clinicaltrials.gov
Start Date
August 1, 2024
End Date
August 1, 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Has had a DEXA scan
  • Has had a DEXA scan

Exclusion Criteria

  • Unable to complete DEXA scan

Outcomes

Primary Outcomes

To assess the newest version of TBS software on fracture prediction

Time Frame: 10 years

Similar Trials